Source: Eur Respir J 2012; 39: 515-517



Rating:

Share or cite this content

Citations should be made in the following way:
Di Candia L., Saunders R., Brightling C.E.. The RAGE against the storm. Eur Respir J 2012; 39: 515-517

Member's Comments

No comment yet.

Related content which might interest you: RAGE and sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005 Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Soluble RAGE is deficient in neutrophilic asthma and COPD Source: Eur Respir J 2012; 39: 721-729 Year: 2012 Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 RAGE blocking ameliorates cigarette smoke extract-induced human alveolar tpye II epithelial cell injury via RAGE-mediated redox sensitive DAMP signaling through Nrf2 Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Organophosphorus pesticides increase inflammatory cytokines by activating macrophage Mac-1 Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Interleukin-18 and interleukin-18 receptor-? expression in allergic asthma Source: Eur Respir J 2011; 38: 981-983 Year: 2011 Receptor for advanced glycation end products contributes to particulate induced lung function loss and hyperreactivity: Mitigating the effects of a single intense particulate exposure Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome Source: Eur Respir J, 56 (4) 2003006; 10.1183/13993003.03006-2020 Year: 2020 Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor Source: Eur Respir J 2010; 36: 1143-1154 Year: 2010 Adaptation to organic dust exposure: a potential role of l-selectin shedding? Source: Eur Respir J 2002; 19: 833-837 Year: 2002 RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 FPS-ZM1-induced blocking of RAGE alleviates elastase-induced emphysema development by preventing RAGE-DAMP-Nrf2 signaling Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 Ang-1/BMPR2 signaling and the expressions of MCP-1 and ICAM in over circulation-induced experimental pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 533s Year: 2004 The upregulation of CD-11B expression on circulating neutrophils by CXCL8 and the involvement of CXCR1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006